Stay updated on Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details, with a basic header and footer shown during the inaccessible state.
    Difference
    19%
    Check dated 2026-09-20T20:09:58.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The site deployment updated the revision from v3.6.5 to v3.6.6, indicating a new software release; this appears to be behind-the-scenes maintenance rather than content changes.
    Difference
    0.1%
    Check dated 2026-08-30T21:58:12.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page gains links to additional study documents and related metadata (consent form addenda, the protocol and SAP, IPD plan, and publications), expanding reference materials for investigators and potential participants.
    Difference
    54%
    Check dated 2026-08-16T15:47:47.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5. This reflects a minor maintenance update rather than a substantive change to study content or features.
    Difference
    0.1%
    Check dated 2026-08-09T10:00:35.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3, reflecting a newer build or patch.
    Difference
    0.1%
    Check dated 2026-07-25T23:27:14.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small internal update to the page's metadata. The visible content and study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-04T13:32:09.000Z thumbnail image

Stay in the know with updates to Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.